€9.8m ERC Synergy grant awarded to study how human tissues stay healthy as we age
5th November 2024
Researchers at the BCI and the Crick have been awarded a €9.8m ERC Synergy grant for their pioneering 6-year project called MUTAHOME.
Read more
BCI paves the way for the next era of radiation research in £18m partnership
30th October 2024
The BCI is advancing radiation research through the Cancer Reserach UK City of London Radiation Research Centre of Excellence, an £18M partnership with the Crick, UCL and King’s.
Read more
International study reveals four distinct types of oesophageal cancer
23rd October 2024
New research reveals that the most common type of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC), is composed of four distinct subtypes—each of which may benefit from different treatment approaches.
Read more
Scientists uncover promising leukaemia treatment targeting fat metabolism
17th October 2024
Researchers at Barts Cancer Institute reveal promising acute myeloid leukaemia treatment targeting fat metabolism, addressing the urgent need for better therapies.
Read more
Helping cancer patient advocates find their voice
10th October 2024
We recently welcomed a group of 16 cancer patient advocates into our labs for the 11th edition of our VOICE science for advocates course, co-run with the charity Independent Cancer Patients’ Voice.
Read more
BCI part of new UK-wide cancer immunotherapy initiative
7th October 2024
Researchers from Barts Cancer Institute, Queen Mary University of London are part of a nationwide team of universities, hospitals and industry collaborating on a new platform to understand immunotherapy response and side effects in cancer.
Read more